After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ABT belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. The current market capitalization of Abbott Laboratories is $231.50B. A total of 6.28 million shares were traded on the day, compared to an average of 7.11M shares.
In the most recent transaction, Blount Sally E. sold 2,600 shares of ABT for 129.66 per share on Apr 30 ’25. After the transaction, the Director now owns 34,058 company shares. In a previous transaction on Apr 30 ’25, SALLY E BLOUNT bought 2,600 shares at 129.66 per share.
Among the insiders who sold shares, Earnhardt Lisa D disposed of 91,167 shares on Mar 06 ’25 at a per-share price of $133.82. This resulted in the EVP AND GROUP PRESIDENT holding 71,928 shares of ABT after the transaction. In another insider transaction, Earnhardt Lisa D sold 200 shares at $136.65 per share on Mar 07 ’25. Company shares held by the EVP AND GROUP PRESIDENT now total 71,928.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Abbott Laboratories pays an annual dividend of $2.28, resulting in a dividend yield of 1.71%, and it has a price to earnings (P/E) ratio of 17.26. ABT’s most recent ex-dividend date was 1.75% when it declared a $0.59 quarterly dividend that was paid in cash on 4/15/2025. Previously, the company paid the dividend on 1/15/2025 with an ex-dividend date of 2.08%. The ABT stock dividend was $0.59 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ABT has a high of $141.23 and a low of $99.71.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ABT’s latest balance sheet shows that the firm has $10.25B in Cash & Short Term Investments as of fiscal 2021. There were $19.01B in debt and $13.11B in liabilities at the time. Its Book Value Per Share was $28.05, while its Total Shareholder’s Equity was $36.02B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABT is Buy with a score of 4.44.
